1-17 of 17
Jerome Ritz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PR11: Allogeneic memory-like natural killer (NK) cell therapy with IL-15 superagonist with or without ipilimumab for advanced, incurable head and neck cancer: A phase 1 trial

Glenn J. Hanna, Roman M. Shapiro, Michal Sheffer, Michela Ansuinelli, Grace Birch, Robert A. Redd, Alejandro Alonso, Denbaa Bat-Erdene, Samantha Himberg, Heather Daley, Diego E. Hernandez-Rodriquez, Katharin L. Shaw, Jerome Ritz, Sarah Nikiforow, Robert J. Soiffer, Rizwan Romee
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (18_Supplement): PR11.
https://doi.org/10.1158/1557-3265.AACRAHNS23-PR11
Published: 15 September 2023
View article titled, Abstract PR11: Allogeneic memory-like natural killer (NK) cell therapy with IL-15 superagonist with or without ipilimumab for advanced, incurable head and neck cancer: A phase 1 trial
Journal Articles

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Mark A. Exley, Phillip Friedlander, Nadia Alatrakchi, Lianne Vriend, Simon Yue, Tetsuro Sasada, Wanyong Zeng, Yo Mizukami, Justice Clark, David Nemer, Kenneth LeClair, Christine Canning, Heather Daley, Glenn Dranoff, Anita Giobbie-Hurder, F. Stephen Hodi, Jerome Ritz, Steven P. Balk
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (14): 3510–3519.
https://doi.org/10.1158/1078-0432.CCR-16-0600
Published: 13 July 2017
View article titled, Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
Open the PDF for Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Biologic Activity of Autologous, Granulocyte–Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines

John M. Goldberg, David E. Fisher, George D. Demetri, Donna Neuberg, Stephen A. Allsop, Catia Fonseca, Yukoh Nakazaki, David Nemer, Chandrajit P. Raut, Suzanne George, Jeffrey A. Morgan, Andrew J. Wagner, Gordon J. Freeman, Jerome Ritz, Cecilia Lezcano, Martin Mihm, Christine Canning, F. Stephen Hodi, Glenn Dranoff
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3178–3186.
https://doi.org/10.1158/1078-0432.CCR-14-2932
Published: 14 July 2015
View article titled, Biologic Activity of Autologous, Granulocyte–Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines
Open the PDF for Biologic Activity of Autologous, Granulocyte–Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines in another window
Journal Articles

Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions

Matthias Piesche, Vincent T. Ho, Haesook Kim, Yukoh Nakazaki, Michael Nehil, Nasser K. Yaghi, Dmitriy Kolodin, Jeremy Weiser, Peter Altevogt, Helena Kiefel, Edwin P. Alyea, Joseph H. Antin, Corey Cutler, John Koreth, Christine Canning, Jerome Ritz, Robert J. Soiffer, Glenn Dranoff
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (5): 1010–1018.
https://doi.org/10.1158/1078-0432.CCR-14-1956
Published: 01 March 2015
View article titled, Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions
Open the PDF for Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions in another window
Includes: Supplementary data
Journal Articles

Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion

Wandi Zhang, Jaewon Choi, Wanyong Zeng, Shelby A. Rogers, Edwin P. Alyea, James G. Rheinwald, Christine M. Canning, Vladimir Brusic, Tetsuro Sasada, Ellis L. Reinherz, Jerome Ritz, Robert J. Soiffer, Catherine J. Wu
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (10): 2729–2739.
https://doi.org/10.1158/1078-0432.CCR-10-0415
Published: 13 May 2010
View article titled, Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion
Open the PDF for Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion in another window
Includes: Supplementary data
Journal Articles

Diverse Patterns of T-Cell Response against Multiple Newly Identified Human Y Chromosome–Encoded Minor Histocompatibility Epitopes

Yishai Ofran, Haesook T. Kim, Vladimir Brusic, Loren Blake, Michael Mandrell, Catherine J. Wu, Stefanie Sarantopoulos, Roberto Bellucci, Derin B. Keskin, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (5): 1642–1651.
https://doi.org/10.1158/1078-0432.CCR-09-2701
Published: 28 February 2010
View article titled, Diverse Patterns of T-Cell Response against Multiple Newly Identified Human Y Chromosome–Encoded Minor Histocompatibility Epitopes
Open the PDF for Diverse Patterns of T-Cell Response against Multiple Newly Identified Human Y Chromosome–Encoded Minor Histocompatibility Epitopes in another window
Journal Articles

Revealing Tumor Immunity after Hematopoietic Stem Cell Transplantation

Catherine J. Wu, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (14): 4515–4517.
https://doi.org/10.1158/1078-0432.CCR-09-0873
Published: 15 July 2009
View article titled, Revealing Tumor Immunity after Hematopoietic Stem Cell Transplantation
Open the PDF for Revealing Tumor Immunity after Hematopoietic Stem Cell Transplantation in another window
Includes: Supplementary data
Journal Articles

Targets of Tumor Immunity After Allogeneic Hematopoietic Stem Cell Transplantation

Yishay Ofran, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 4997–4999.
https://doi.org/10.1158/1078-0432.CCR-08-0857
Published: 12 August 2008
View article titled, Targets of Tumor Immunity After Allogeneic Hematopoietic Stem Cell Transplantation
Open the PDF for Targets of Tumor Immunity After Allogeneic Hematopoietic Stem Cell Transplantation in another window
Includes: Supplementary data
Journal Articles

Introducing CCR Translations

Carlos L. Arteaga, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (15): 4681.
https://doi.org/10.1158/1078-0432.CCR-14-15-ED
Published: 01 August 2008
View article titled, Introducing <em>CCR Translations</em>
Open the PDF for Introducing <em>CCR Translations</em> in another window
Journal Articles

High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease

Stefanie Sarantopoulos, Kristen E. Stevenson, Haesook T. Kim, Nazmim S. Bhuiya, Corey S. Cutler, Robert J. Soiffer, Joseph H. Antin, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (20): 6107–6114.
https://doi.org/10.1158/1078-0432.CCR-07-1290
Published: 18 October 2007
View article titled, High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease
Open the PDF for High Levels of B-Cell Activating Factor in Patients with Active Chronic Graft-Versus-Host Disease in another window
Journal Articles

Studying Human Regulatory T Cells In vivo

Emmanuel Zorn, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (18): 5265–5267.
https://doi.org/10.1158/1078-0432.CCR-06-1417
Published: 25 September 2006
View article titled, Studying Human Regulatory T Cells <em>In vivo</em>
Open the PDF for Studying Human Regulatory T Cells <em>In vivo</em> in another window
Journal Articles

Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation

Sabina Chiaretti, Xiaochun Li, Robert Gentleman, Antonella Vitale, Kathy S. Wang, Franco Mandelli, Robin Foà, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (20): 7209–7219.
https://doi.org/10.1158/1078-0432.CCR-04-2165
Published: 20 October 2005
View article titled, Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation
Open the PDF for Gene Expression Profiles of B-lineage Adult Acute Lymphocytic Leukemia Reveal Genetic Patterns that Identify Lineage Derivation and Distinct Mechanisms of Transformation in another window
Includes: Supplementary data
Journal Articles

Graft-versus-Leukemia Target Antigens in Chronic Myelogenous Leukemia Are Expressed on Myeloid Progenitor Cells

Catherine J. Wu, Melinda Biernacki, Jeffery L. Kutok, Shelby Rogers, Linyun Chen, Xiao-Feng Yang, Robert J. Soiffer, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4504–4511.
https://doi.org/10.1158/1078-0432.CCR-05-0036
Published: 15 June 2005
View article titled, Graft-versus-Leukemia Target Antigens in Chronic Myelogenous Leukemia Are Expressed on Myeloid Progenitor Cells
Open the PDF for Graft-versus-Leukemia Target Antigens in Chronic Myelogenous Leukemia Are Expressed on Myeloid Progenitor Cells in another window
Journal Articles

Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- versus -Host Disease

Daniel J. DeAngelo, Ephraim P. Hochberg, Edwin P. Alyea, Janina Longtine, Stephanie Lee, Ilene Galinsky, Ben Parekkedon, Jerome Ritz, Joseph H. Antin, Richard M. Stone, Robert J. Soiffer
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5065–5071.
https://doi.org/10.1158/1078-0432.CCR-03-0580
Published: 05 August 2004
View article titled, Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: <subtitle>Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- <em>versus</em> -Host Disease</subtitle>
Open the PDF for Extended Follow-up of Patients Treated with Imatinib Mesylate (Gleevec) for Chronic Myelogenous Leukemia Relapse after Allogeneic Transplantation: <subtitle>Durable Cytogenetic Remission and Conversion to Complete Donor Chimerism without Graft- <em>versus</em> -Host Disease</subtitle> in another window
Journal Articles

Imatinib Therapy for Patients with Chronic Myelogenous Leukemia: Are Patients Living Longer?

Daniel J. DeAngelo, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (1): 1–3.
https://doi.org/10.1158/1078-0432.CCR-1218-3
Published: 20 January 2004
View article titled, Imatinib Therapy for Patients with Chronic Myelogenous Leukemia: <subtitle>Are Patients Living Longer?</subtitle>
Open the PDF for Imatinib Therapy for Patients with Chronic Myelogenous Leukemia: <subtitle>Are Patients Living Longer?</subtitle> in another window
Journal Articles

Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells

Emmanuel Zorn, Kathy S. Wang, Ephraim P. Hochberg, Christine Canning, Edwin P. Alyea, Robert J. Soiffer, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2052–2060.
Published: 01 July 2002
View article titled, Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells
Open the PDF for Infusion of CD4+ Donor Lymphocytes Induces the Expansion of CD8+ Donor T Cells with Cytolytic Activity Directed against Recipient Hematopoietic Cells in another window
Journal Articles

Immunological Effects of Interleukin 12 Administered by Bolus Intravenous Injection to Patients with Cancer

Michael J. Robertson, Christine Cameron, Michael B. Atkins, Michael S. Gordon, Michael T. Lotze, Matthew L. Sherman, Jerome Ritz
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (1): 9–16.
Published: 01 January 1999
View article titled, Immunological Effects of Interleukin 12 Administered by Bolus Intravenous Injection to Patients with Cancer
Open the PDF for Immunological Effects of Interleukin 12 Administered by Bolus Intravenous Injection to Patients with Cancer in another window